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Normal minipuberty in a patient with DAX-1 mutation: additional evidence of a differential role for 
DAX-1 during development?   
DAX-1 gene encodes for an orphan member of the nuclear receptor superfamily. Dax-1 is expressed 
in the adrenal cortex, gonads, hypothalamus and anterior pituitary. DAX1 is known to play a critical 
role in the development of the hypothalamic-pituitary-adrenal axis. Its role in regulation of the 
hypothalamic-pituitary-gonadal axis is still debated. 
Here we report the case of a five week-old male patient, referred to the hospital because of failure to 
thrive. An adrenal insufficiency was diagnosed and the genetic testing showed a nonsense mutation 
in exon 1 of the DAX-1 gene. 
Classically, mutations in the DAX-1 gene cause an adrenal hypoplasia congenita associated with 
adrenal insufficiency and hypogonadotrophic hypogonadism.   
In our patient, physical examination showed normal male sexual differentiation (normal penile length 
and descended testes) and the laboratory evaluation reveals a normal minipuberty onset (basal 
testosterone: 1.9 µg/L; LH: 1.3 UI/L and FSH: 6.3 UI/L at 10 weeks of age) suggesting normal function 
of the pituitary-gonadal axis during the perinatal period.  
DAX-1 mutations are classically reported to cause hypogonadotrophic hypogonadism. Our 
observation as well as gonadotropin-dependent precocious puberty in a patient with a similar 
nonsense mutation (Horm. Res. Paediatr., Darcan et al, 2011) suggest that hypothalamic-pituitary-
gonadal function could not be impaired till adolescence or adulthood in patients with DAX1 
mutations. Accordingly, DAX-1 might not be a major player in the early life activation of the 
hypothalamic-pituitary-gonadal axis while it could be involved in the central control of reproduction 
later in life. This further highlights the difficulty for clinicians to predict pubertal timing and 
reproductive functions in patients with DAX-1 mutation. 
 
 
